Vascular calcification mechanisms

被引:429
作者
Giachelli, CM [1 ]
机构
[1] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2004年 / 15卷 / 12期
关键词
D O I
10.1097/01.ASN.0000145894.57533.C4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Vascular calcification is highly correlated with cardiovascular disease mortality, especially in patients with ESRD or diabetes. In addition to the devastating effects of inappropriate biomineralization seen in cardiac valvulopathies, calciphylaxis, and idiopathic arterial calcification, vascular calcification is now recognized as a marker of atherosclerotic plaque d burden as well as a major contributor to loss of arterial compliance and increased pulse pressure seen with age, diabetes, and renal insufficiency. In recent years, several mechanisms to explain vascular calcification have been identified including circulating nucleational complexes, and (4) cell death. Alterations in calcium (Ca) and phosphorus (P) balance as seen in patients with ESRD promotes vascular calcification via multiple mechanisms and may explain the alarmingly high levels of cardiovascular disease deaths in these patients. Strategies to control Ca and P levels in patients with ESRD have met with early success in preventing progression of vascular calcification. Whether or not vascular calcification can be reversed is not yet known, but exciting new studies suggest that this may be possible in the future.
引用
收藏
页码:2959 / 2964
页数:6
相关论文
共 61 条
[1]  
BEADENKOPF WG, 1964, AMER J ROENTGENOL RA, V92, P865
[2]  
Block GA, 2000, CLIN NEPHROL, V54, P318
[3]   BONE MORPHOGENETIC PROTEIN EXPRESSION IN HUMAN ATHEROSCLEROTIC LESIONS [J].
BOSTROM, K ;
WATSON, KE ;
HORN, S ;
WORTHAM, C ;
HERMAN, IM ;
DEMER, LL .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1800-1809
[4]  
Burke AP, 2000, Z KARDIOL, V89, P49
[5]   Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells [J].
Chen, NX ;
O'Neill, KD ;
Duan, D ;
Moe, SM .
KIDNEY INTERNATIONAL, 2002, 62 (05) :1724-1731
[6]   The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients [J].
Chertow, GM ;
Raggi, P ;
McCarthy, JT ;
Schulman, G ;
Silberzweig, J ;
Kuhlik, A ;
Goodman, WG ;
Boulay, A ;
Burke, SK ;
Toto, RD .
AMERICAN JOURNAL OF NEPHROLOGY, 2003, 23 (05) :307-314
[7]   Slowing the progression of vascular calcification in hemodialysis [J].
Chertow, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (09) :S310-S314
[8]   Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients [J].
Chertow, GM ;
Burke, SK ;
Raggi, P .
KIDNEY INTERNATIONAL, 2002, 62 (01) :245-252
[9]   Cutaneous necrosis from calcific uremic arteriolopathy [J].
Coates, T ;
Kirkland, GS ;
Dymock, RB ;
Murphy, BF ;
Brealey, JK ;
Mathew, TH ;
Disney, APS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (03) :384-391
[10]   The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats [J].
Cozzolino, M ;
Dusso, AS ;
Liapis, H ;
Finch, J ;
Lu, Y ;
Burke, SK ;
Slatopolsky, E .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (09) :2299-2308